CLB
Get informed when a big investor buys or sells
+ FollowOvervalued by 31.1% based on the discounted cash flow analysis.
| Market cap | $576.21 Million |
|---|---|
| Enterprise Value | $592.79 Million |
| Dividend Yield | $0.04 (0.32%) |
| Earnings per Share | $0.68 |
| Beta | 1.08 |
| Outstanding Shares | 46,878,000 |
| P/E Ratio | 22.32 |
|---|---|
| PEG | -50.73 |
| Price to Sales | 1.14 |
| Price to Book Ratio | 2.5 |
| Enterprise Value to Revenue | 1.14 |
| Enterprise Value to EBIT | 12.41 |
| Enterprise Value to Net Income | 22 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.14 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0291▼ 12.15% |
|---|---|
| Total Calls | 10,300▼ 56.90% |
| Total Puts | 300▼ 91.67% |
Holdings and activity of institutional investors.
| Ownership % | 113.62%▲ 3.94% |
|---|---|
| Total Invested | $619.44M▼ 26.99% |
| Investors Holding | 189▼ 3.00% |
No data
Core Laboratories N.V. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70 offices in more tha...